If not, you can flip the stock at any time for a profit. Investors have seriously recognized biotechnology as a distinct market sector since 1993. The Biotechnology Innovation Organization (BIO ...

Biotech is one of the U.S. stock market’s most unloved sectors. But several indicators suggest that a bottom in sentiment could be near, and that’s normally a good time to buy. Here are the ...

Argus has a "buy" rating and $400 price target for UTHR stock, which closed at $362.33 on Jan. 7. Bio-Techne develops, manufactures and sells biotechnology reagents and instruments for the ...

The improved sales of Nerlynx have been the primary reason for the stock’s increase in the past six months. Puma Biotechnology in-licensed the global development and commercialization rights to ...